DocWire News Editors

DocwireNews

Low-dose ibutilide was useful in identifying patients with persistent atrial fibrillation (<a href="https://www.docwirenews.com/condition-center/diverse-activation-patterns-during-persistent-atrial-fibrillation-by-noncontact-charge-density-mapping-of-human-atrium-2/">AFib</a>) in whom pulmonary vein isolation was shown effective as a sole therapy, new study results suggest.&ldquo;Circumferential pulmonary vein isolation can be effective as sole treatment for persistent atrial fibrillation,&rdquo; the authors wrote. &ldquo;However, identifying those patients who will respond to this therapy remains a challenge.&rdquo;The authors looked specifically at the clinical value of sequential low-dose ibutilide testing to identify those with persistent AFib and in whom pulmonary vein isolation was effective by itself as a sole therapy. The prospective cohort consisted of 180 consecutive patients with persistent AFib. Patients were given intravenous low-dose (0.004 mg/kg) ibutilide three days prior to ablation and again after completion of pulmonary vein isolation. Patients in whom the pre-procedural ibutilide did not stop AFib, but did stop it during the procedure, did not have additional atrial substrate modification.The authors reported that pre-procedural ibutilide did not terminate arrhythmia in patients with persistent AFib, but the combination of pulmonary vein isolation and ibutilide stopped AFib in 55 (30.6%) patients (PsAF group 1). For the remaining patients, electrogram-based ablation was performed (n=125; PsAF group 2). Patients were compared to 379 controls who had paroxysmal AFib and who underwent pulmonary vein isolation during the same period. According to the study results, 39 patients in PsAF group 1 and 276 controls were free from atrial tachycardia. Arrhythmia-free rates in both groups were higher than in PsAF group 2 (58.4%; P=0.005).&ldquo;The sequential low-dose ibutilide test is a simple method for identifying patients with persistent AFib in whom pulmonary vein isolation alone is an appropriate treatment strategy,&rdquo; the authors wrote.The study was published in <a href="https://academic.oup.com/europace/article-abstract/22/8/1197/5854842?redirectedFrom=fulltext">EP Europace.</a>

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

Latest News

Low-dose Ibutilide Helps ID AFib Patients In Whom Pulmonary Vein Isolation Works

Atrial Fibrillation

Low-dose ibutilide was useful in identifying patients with persistent atrial fibrillation (AFib) in whom pulmonary vein isolation was shown effective as a sole therapy, new ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe